Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of Brodalumab in Pustular Psoriasis (Generalized) and Psoriatic Erythroderma
jRCT2080222011Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jan 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brodalumab in pustular psoriasis and erythrodermic psoriasis (EP), sponsored by Kyowa Kirin.
02
Drugs
brodalumab
03
Conditions
pustular psoriasiserythrodermic psoriasis (EP)
Beyond the preview
Go deeper on jRCT2080222011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222011.